Health

  • July 27, 2026

    Laid-Off Fed. Workers Lose Bid For Reinstatement Injunction

    A Maryland federal judge won't reinstate a group of former federal workers who claim that their layoffs were ideologically motivated, denying Monday the workers' request for a preliminary injunction in their dispute with the federal government.

  • July 27, 2026

    Cooley Owes $25.4M Judgment To NJ Biotech Co. Founder

    A New Jersey state court on Monday entered a $25.4 million judgment against Cooley LLP after a jury found the multinational firm had committed malpractice in its representation of a biotech founder who said his own lawyers assisted in shoving him out of his company.

  • July 27, 2026

    Quinn Emanuel's Ethics Training 'Promising,' Judge Says

    A California federal judge Monday approved a court-ordered ethics training program prepared by Quinn Emanuel in the wake of misrepresentations the firm made concerning an expert in a false advertising suit brought by Guardant Health against its client Natera, saying the firm had designed an "extremely promising" eight-hour program.

  • July 27, 2026

    Health Data Co. Inks $4.8M Settlement To End Investor Suit

    The health diagnostics company formerly known as Sema4 has reached a $4.8 million settlement with investors accusing the company of misleading them about a nonexistent, artificial intelligence-driven data platform it claimed to operate.

  • July 27, 2026

    AbbVie Seeks Block On Alkem Generic Constipation Drug

    AbbVie Inc. and collaborator Ironwood Pharmaceuticals urged a New Jersey federal court to bar India-based generic-drug maker Alkem Laboratories from selling generic versions of their branded constipation drug while associated patents are active, arguing Alkem would violate patent law by doing so.

  • July 27, 2026

    Ill. Heart Clinic Sued For Breach Compromising Patient Data

    A heart care clinic with multiple locations in the Chicago area has been hit with proposed class privacy claims from patients who say their personal identifying and health information has been compromised in a data hack that the provider failed to publicly acknowledge for six months.

  • July 27, 2026

    Insurance Services Co. Can Fix Worker Tax Credit Refund Bid

    A U.S. Court of Federal Claims judge allowed a California-based health and life insurance services company to amend its complaint to address questions about whether it qualified as an eligible employer to claim a $50,000 employee retention tax credit refund.

  • July 27, 2026

    Trade Group Can't Challenge Calif. PBM Law

    A healthcare industry group representing pharmacy benefit managers lost its initial bid to challenge a California state law restricting their business practices, after a federal judge determined its complaint didn't go far enough to prove standing for the group representing PBMs, which intermediate between drugmakers, pharmacies and insurers.

  • July 27, 2026

    Judge Refuses To Pause Coverage Fight Over Boy's Death

    A Michigan federal judge ruled Friday that Nationwide Insurance may proceed with its declaratory judgment lawsuit against the Oxford Hyperbaric Oxygen Therapy Center and the parents of a 5-year-old boy killed at the facility, noting that the insurance coverage dispute addresses issues separate from pending state civil and criminal cases involving the center.

  • July 27, 2026

    Cannabis In The Courts: A Midyear Litigation Review

    In the first half of 2026, lawsuits taking aim at recent federal shifts in cannabis policy, a federal ban on marijuana users owning firearms and purported residency criteria in state cannabis licensure programs were argued in multiple courts across the country.

  • July 27, 2026

    Weill Cornell Medicine Settles Doctor Sex Abuse Probe

    Weill Cornell Medicine reached a settlement on Monday with Manhattan federal prosecutors to end a criminal investigation into allegations that the prestigious medical and graduate school failed to prevent one of its doctors from sexually abusing patients for more than a decade.

  • July 24, 2026

    Abbott Wins 7th Circ. Fight Over Baby Formula Warning

    The Seventh Circuit on Friday refused to revive a woman's claims that Abbott Laboratories failed to warn about the dangers of a Similac-brand infant formula her baby drank before dying of a serious gastrointestinal disease, saying she failed to show that her suggested alternative warning would have saved her baby.

  • July 24, 2026

    Va. Court Orders FDA To Reconsider Mifepristone Restrictions

    A Virginia federal judge held that a 2023 regulation by the U.S. Food and Drug Administration unlawfully placed prescribing restrictions on the abortion drug mifepristone, agreeing with a group of abortion providers that the agency inadequately addressed burdens on the healthcare system.

  • July 24, 2026

    Insulin Pen Lawsuit Against Novo Nordisk Headed For Trial

    A Connecticut federal judge refused on Friday to give Griffin Health Services Corp. a loss in its lawsuit over allegedly inadequate warnings on Novo Nordisk insulin pens, finding the hospital raised triable questions about whether the company failed to alert nurses to contamination risks and criticizing Novo for filing multiple summary judgment motions.

  • July 24, 2026

    FDA, CDC Broaden Cyclospora Outbreak To 9 States

    The U.S. Food and Drug Administration and the Centers for Disease Control and Prevention said Friday that the investigation into the ongoing cyclospora outbreak linked to iceberg lettuce has now expanded into four more states, bringing the total to nine.

  • July 24, 2026

    Fordham Scholar On Neuroscience's Role In Criminal Courts

    Neuroscience has become an increasingly common feature of criminal litigation, shaping everything from death penalty mitigation to juvenile sentencing. Yet many of the assumptions surrounding brain science in the courtroom remain wrong, Fordham Law School Professor Deborah Denno told Law360.

  • July 24, 2026

    'Irreparable': The Lasting Harm Of Justices' Temporary Orders

    The U.S. Supreme Court has considered dozens of emergency petitions involving executive policies since President Donald Trump's return to office. While justices often defend their emergency rulings as stop-gap measures, people at the center of those cases — who've lost their legal status, jobs, or federal funding — say that even interim decisions have had lasting effects on their lives.

  • July 24, 2026

    Pet Medical Co. Sheds Dog Arthritis Drug Suit For Good

    A New Jersey federal judge has thrown out for good a proposed nationwide class action alleging Zoetis Inc. hid the dangerous side effects of its canine osteoarthritis drug, finding the complaint failed to plead the plaintiffs relied on any misrepresentations to their dogs' detriment.

  • July 24, 2026

    Federal Bill Seeks CDC Set-Aside For Tribal Health

    A coalition of U.S. lawmakers from New Mexico and U.S. Sen. Elizabeth Warren, D-Mass., have introduced legislation that would guarantee that tribal nations have equal access to the Centers for Disease Control and Prevention's Public Health Emergency Preparedness program.

  • July 24, 2026

    Yale Age Test, Allergy Death, Wine Royalties: A Midyear Report

    In the second half of 2026, Connecticut courts are being called upon to decide closely watched issues such as whether the state's largest hospital group violated federal disability and age discrimination laws when requiring providers over age 70 to undergo mandatory cognitive tests.

  • July 24, 2026

    Wellstar To Pay $4.25M To End Patient Data-Sharing Suit

    Wellstar Health System Inc. will pay $4.25 million to resolve a proposed class action alleging it used tracking and collection tools to share confidential health information with Meta Platforms and Google without patients' consent, according to a federal court filing.

  • July 24, 2026

    Mental Health Agency Sues Mass. Prison System For Records

    A Massachusetts mental health legal advocacy committee has filed a lawsuit against the state's department of correction, claiming it was denied access to data about health services provided in one state prison by a private contractor.

  • July 24, 2026

    Novo Asks NJ Judge To Stop Lilly's 'Deceptive' GLP-1 Ads

    Novo Nordisk Inc. asked a New Jersey federal court Friday to block rival Eli Lilly & Co. from running ads allegedly comparing their respective GLP-1 drugs using "outdated" clinical trials and "false superiority messages," arguing the ads are damaging its reputation and misleading consumers.

  • July 24, 2026

    Surgical Co. Trims Tobacco Fee Suit In Texas

    A Texas federal judge pared some claims from a proposed class action alleging that a surgical company wrongly imposed a surcharge on the health plans of workers who used tobacco, while opening discovery on other allegations she found had stated a claim for violating federal benefits law.

  • July 24, 2026

    Top Product Liability Cases Of 2026: Midyear Report

    In one of the most-watched cases for product liability so far this year, the U.S. Supreme Court ruled that failure-to-warn claims about the alleged cancer risks of Monsanto's widely used pesticide Roundup are barred by federal law. Social media titans were also rocked by the first verdicts delivered in cases alleging mental health harms to youth.

Expert Analysis

  • Del. Blackbaud Ruling Signals A New Era For Cyberinsurance

    Author Photo

    The recent Delaware Supreme Court ruling in Travelers v. Blackbaud shows that cyberinsurance is moving into a second maturity phase, in which insurers will increasingly attempt to recover their payments from vendors and insureds will face new pressure to justify cyber incident reimbursements, say Steven Teppler at Mandelbaum Barrett and Jade Davis at Shumaker.

  • Opinion

    AI Presents A Make-Or-Break Moment For Outside Counsel

    Author Photo

    The rapid adoption of artificial intelligence by corporate legal departments is forcing a long-overdue reset of the relationship between inside and outside counsel, and introducing a significant opportunity to shed frustrating inefficiencies and strengthen collaboration for firms willing to embrace the shift, says Intel Chief Legal Officer April Miller Boise.

  • DOJ Actions Suggest Expansion Of Healthcare Enforcement

    Author Photo

    Recent actions by the U.S. Department of Justice and U.S. Food and Drug Administration suggest that federal healthcare enforcement efforts are moving away from traditional program-based fraud and toward cases centered on product integrity, regulatory transparency and telehealth marketing, effectively widening the government's enforcement playbook, say attorneys at MoFo.

  • Series

    Watching Hallmark Movies Makes Me A Better Lawyer

    Author Photo

    I realize you may be judging me for watching, and actually enjoying, Hallmark Channel movies, but the escapism and storylines actually demonstrate qualities and actions that lead to an efficient, productive and positive legal practice, says Karen Ross at Tucker Ellis.

  • New Orphan Drug Law Provides A Key Fix For Pharma Cos.

    Author Photo

    The Consolidated Appropriations Act enacted last month restores the U.S. Food and Drug Administration's long-standing interpretation of "same disease or condition," related to orphan drug exclusivity, resolving years of regulatory uncertainty and litigation that have discouraged rare disease research, say attorneys at Spencer Fane.

  • FDA User Fee Talks Offer Clues On Upcoming Reforms

    Author Photo

    As the U.S. Food and Drug Administration undergoes the User Fee Act reauthorization process and renegotiates its user fee agreements over the next several months, the agency's consultation meetings with relevant industries can shed light on the FDA's priorities, and provides stakeholders an opportunity to participate in the reform process, say attorneys at Holland & Knight.

  • Changes Coming To The SBIR And STTR Programs

    Author Photo

    Legislation recently approved by Congress to reauthorize the Small Business Innovation Research and Small Business Technology Transfer Programs includes changes focused on national security that would improve transparency but also increase applicants' administrative burdens, slow the awards process and likely increase litigation, say attorneys at Fluet & Associates.

  • FDA Framework For Personalized Therapies Raises Questions

    Author Photo

    The U.S. Food and Drug Administration's new plausible mechanism framework for developing individualized therapies reflects the agency's focus on rare-disease drugs, but numerous significant, unresolved issues cast uncertainty on how effective the framework will be in practice, say attorneys at Ropes & Gray.

  • 5 Tips For Navigating Your Firm's All-Attorney Summit

    Excerpt from Practical Guidance
    Author Photo

    Law firm retreats should be approached strategically, as they present valuable opportunities to advance both the firm's objectives and attorneys' professional development through meaningful participation, building and strengthening internal relationships, and proactive follow-up, says James Argionis at Cozen O’Connor.

  • Scrutiny Of Nursing Home Practices Marks Inflection Point

    Author Photo

    Recent congressional inquiries into UnitedHealth Group's Medicare Advantage-linked nursing home practices raise questions about whether financial metrics are allowed to influence decisions governed by the standard of care, and could implicate duties imposed by federal regulations, state negligence laws and elder abuse statutes, says Lindsey Gale at Rafferty Domnick.

  • Series

    Coaching Soccer Makes Me A Better Lawyer

    Author Photo

    Coaching youth soccer for my 7-year-old son's team has sharpened how I communicate with clients, prepare witnesses, work within teams and think about leadership, making me a more thoughtful and effective lawyer in many ways, says Joshua Holt at Smith Currie.

  • Series

    Law School's Missed Lessons: The Human Element

    Author Photo

    Law school teaches you to quickly apply intellect and logic when handling a legal issue, but every fact pattern also involves a person, making the ability to balance expertise with empathy critical to the growth of relationships with clients, colleagues and adversaries, says Rachel Adcox at Adcox Strategies.

  • CMS Healthcare Enforcement Initiatives May Cause Disruption

    Author Photo

    The Centers for Medicare & Medicaid Services' recently announced enforcement actions against healthcare fraud mark a significant escalation, and CMS' prior approach in the hospice sector suggests that even compliant providers and suppliers should brace for impact, say attorneys at Morgan Lewis.

  • How Cos. Should Prepare For NY RAISE Act Compliance

    Author Photo

    With the New York Responsible AI Safety and Education Act taking effect March 19, state regulators will expect subject artificial intelligence governance policies to understand whether appropriate safeguards and protocols are in place to prevent or mitigate discriminatory or adverse outcomes by frontier models, says Michael Paulino at Gordon Rees.

  • What We Know About DOJ's New FCA Enforcement Priorities

    Author Photo

    Recent remarks from the leader of the Justice Department’s commercial litigation branch provide key insights on how False Claims Act cases — especially healthcare fraud, trade fraud, antidiscrimination and cybersecurity claims — will be evaluated, prioritized and pursued as heightened enforcement becomes the new normal, say attorneys at Latham.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Health archive.